Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
67.22
+3.45 (5.41%)
At close: Aug 13, 2025, 4:00 PM
67.09
-0.13 (-0.19%)
After-hours: Aug 13, 2025, 4:10 PM EDT
Paramount Global Market Cap
Merus has a market cap or net worth of $5.07 billion as of August 13, 2025. Its market cap has increased by 59.55% in one year.
Market Cap
5.07B
Enterprise Value
4.19B
1-Year Change
59.55%
Ranking
Category
Stock Price
$67.22
Market Cap Chart
Since May 19, 2016, Merus's market cap has increased from $143.00M to $5.07B, an increase of 3,448.47%. That is a compound annual growth rate of 47.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 4.82B | 67.54% |
| Dec 31, 2024 | 2.88B | 81.33% |
| Dec 29, 2023 | 1.59B | 121.65% |
| Dec 30, 2022 | 716.30M | -41.96% |
| Dec 31, 2021 | 1.23B | 142.03% |
| Dec 31, 2020 | 509.90M | 55.03% |
| Dec 31, 2019 | 328.90M | 20.92% |
| Dec 31, 2018 | 272.00M | -12.85% |
| Dec 29, 2017 | 312.10M | 3.83% |
| Dec 30, 2016 | 300.60M | 110.21% |
| May 19, 2016 | 143.00M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.74B |
| Johnson & Johnson | 415.22B |
| AbbVie | 349.07B |
| UnitedHealth Group | 235.75B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.42B |
| Novo Nordisk | 222.88B |